Sustained Release of FGF-21 from a Genetically Engineered Injectable Depot for the Treatment of Type 2 Diabetes

被引：0
|
作者：
Gilroy, Caslin A.
Chilkoti, Ashutosh
机构：
来源：
DIABETES | 2017年 / 66卷
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1092-P
引用
收藏
页码：A289 / A289
页数：1
相关论文
共 50 条
  • [31] Pharmacologic Treatment of Type 2 Diabetes: Injectable Medications
    Tran, Linda
    Zielinski, Angela
    Roach, Arpi H.
    Jende, Jennifer A.
    Householder, Ann Marie
    Cole, Emily E.
    Atway, Shuruq A.
    Amornyard, Melinda
    Accursi, Mallory L.
    Shieh, Suzanna W.
    Thompson, Erin E.
    ANNALS OF PHARMACOTHERAPY, 2015, 49 (06) : 700 - 714
  • [32] Recombinant AAV-DJ Vector-Mediated FGF-21/FGF-21-GLP-1 Long-Term Expression in db/db Mice With Type 2 Diabetes Mellitus
    Yang, Hua
    Lin, Yun-Tao
    Wang, Min
    Zhu, Tian-Xiao
    Hu, Ji-Fan
    Chen, Hui-Ling
    MOLECULAR THERAPY, 2014, 22 : S139 - S140
  • [33] Redox-active injectable gel using polyion complex to achieve sustained release of exenatide and enhance therapeutic efficacy for the treatment of type 2 diabetes
    Ishii, Shiro
    Sakaue, Sho
    Nagasaki, Yukio
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2019, 107 (05) : 1107 - 1113
  • [34] Serum concentrations of novel metabolic regulator FGF-21 in patients with obesity and type 2 diabetes mellitus:: The influence of very low calorie diet and PPAR-α agonist treatment
    Mraz, Milos
    Bartlova, Marketa
    Lacinova, Zdena
    Haluzikova, Denisa
    Humenanska, Viera
    Haluzik, Martin
    DIABETES, 2008, 57 : A411 - A411
  • [35] Effects of an FGF21 Analog in Patients With Type 2 Diabetes
    Gaich, Gregory
    Chien, Jenny
    Fu, Haoda
    Kharitonenkov, Alexei
    Moller, David
    DIABETES, 2013, 62 : A28 - A28
  • [36] Pharmacological efficacy of FGF21 analogue, liraglutide and insulin glargine in treatment of type 2 diabetes
    Ye, Xianlong
    Qi, Jianying
    Yu, Dan
    Wu, Yunzhou
    Zhu, Shenglong
    Li, Shujie
    Wu, Qiang
    Ren, Guiping
    Li, Deshan
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (04) : 726 - 734
  • [37] Injectable drug depot engineered to release multiple ophthalmic therapeutic agents with precise time profiles for postoperative treatment following ocular surgery
    Mohammadi, Maziar
    Patel, Kisha
    Alaie, Seyedeh P.
    Shmueli, Ron B.
    Besirli, Cagri G.
    Larson, Ronald G.
    Green, Jordan J.
    ACTA BIOMATERIALIA, 2018, 73 : 90 - 102
  • [38] The effect of 12 weeks of training in water on serum levels of SIRT1 and FGF-21, glycemic index, and lipid profile in patients with type 2 diabetes
    Bahram Jamali Gharakhanlou
    Solmaz Babaei Bonab
    International Journal of Diabetes in Developing Countries, 2022, 42 : 727 - 734
  • [39] The effect of 12 weeks of training in water on serum levels of SIRT1 and FGF-21, glycemic index, and lipid profile in patients with type 2 diabetes
    Gharakhanlou, Bahram Jamali
    Bonab, Solmaz Babaei
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2022, 42 (04) : 727 - 734
  • [40] Serum FGF 21 in Individuals with and Without a Family History of Type 2 Diabetes
    Davis, Greggory R.
    Guillory, Joshua
    Deville, Tiffany
    Bellar, David
    Nelson, Arnold
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2016, 48 (05): : 911 - 911
12345